Organ Transplantation Center, National Center for Child Health and Development, Tokyo, Japan.
Department of Sugery, Kanagawa Children's Medical Center, Yokohama, Japan.
J Pediatr Surg. 2024 Sep;59(9):1791-1797. doi: 10.1016/j.jpedsurg.2024.05.008. Epub 2024 May 17.
Although congenital portosystemic shunts (CPSSs) are increasingly being recognized, the optimal treatment strategies and natural prognosis remain unclear, as individual CPSSs show different phenotypes.
The medical records of 122 patients who were diagnosed with CPSSs at 15 participating hospitals in Japan between 2000 and 2019 were collected for a retrospective analysis based on the state of portal vein (PV) visualization on imaging.
Among the 122 patients, 75 (61.5%) showed PV on imaging. The median age at the diagnosis was 5 months. The main complications related to CPSS were hyperammonemia (85.2%), liver masses (25.4%), hepatopulmonary shunts (13.9%), and pulmonary hypertension (11.5%). The prevalence of complications was significantly higher in patients without PV visualization than in those with PV visualization (P < 0.001). Overall, 91 patients (74.6%) received treatment, including shunt closure by surgery or interventional radiology (n = 82) and liver transplantation (LT) or liver resection (n = 9). Over the past 20 years, there has been a decrease in the number of patients undergoing LT. Although most patients showed improvement or reduced progression of symptoms, liver masses and pulmonary hypertension were less likely to improve after shunt closure. Complications related to shunt closure were more likely to occur in patients without PV visualization (P = 0.001). In 25 patients (20.5%) without treatment, those without PV visualization were significantly more likely to develop complications related to CPSS than those with PV visualization (P = 0.011).
Patients without PV visualization develop CPSS-related complications and, early treatment using prophylactic approaches should be considered, even if they are asymptomatic.
Level III.
虽然先天性门体分流(CPSS)的病例越来越多,但由于个体 CPSS 表现出不同的表型,其最佳治疗策略和自然预后仍不清楚。
本研究回顾性分析了 2000 年至 2019 年间日本 15 家参与医院诊断为 CPSS 的 122 例患者的病历资料,依据影像学上门静脉(PV)显影状态进行分组。
122 例患者中,75 例(61.5%)在影像学上可见 PV。诊断时的中位年龄为 5 个月。与 CPSS 相关的主要并发症包括高氨血症(85.2%)、肝脏肿块(25.4%)、肝肺分流(13.9%)和肺动脉高压(11.5%)。无 PV 显影患者的并发症发生率显著高于有 PV 显影患者(P<0.001)。总体而言,91 例(74.6%)患者接受了治疗,包括手术或介入放射学关闭分流(n=82)和肝移植(LT)或肝切除术(n=9)。过去 20 年来,接受 LT 的患者数量有所减少。尽管大多数患者的症状改善或进展减缓,但分流关闭后肝脏肿块和肺动脉高压不太可能改善。无 PV 显影患者发生分流关闭相关并发症的风险更高(P=0.001)。在 25 例(20.5%)未接受治疗的患者中,无 PV 显影患者发生 CPSS 相关并发症的风险显著高于有 PV 显影患者(P=0.011)。
无 PV 显影的 CPSS 患者易发生 CPSS 相关并发症,即使无症状也应考虑预防性治疗。
III 级。